News25/Ratings0
News · 26 weeks19+700%
2025-12-072026-05-31
Mix1990d
- Insider9(47%)
- SEC Filings4(21%)
- Other3(16%)
- Offering3(16%)
Latest news
25 items- SECSEC Form SCHEDULE 13G filed by Breeze Holdings Acquisition Corp.SCHEDULE 13G - Breeze Acquisition Corp. II (0002095443) (Subject)
- INSIDERCEO, CFO, Chairman Ramsey J Douglas bought 470,000 units of Ordinary Shares and disposed of 131,757 units of Ordinary Shares (SEC Form 4)4 - Breeze Acquisition Corp. II (0002095443) (Issuer)
- INSIDERSponsor entity Breeze Sponsor Ii, Llc disposed of 131,757 units of Ordinary Shares and bought 470,000 units of Ordinary Shares, increasing direct ownership by 7% to 5,248,919 units (SEC Form 4)4 - Breeze Acquisition Corp. II (0002095443) (Issuer)
- SECBreeze Holdings Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits8-K - Breeze Acquisition Corp. II (0002095443) (Filer)
- PRBreeze Acquisition Corp. II Announces Closing of $15,000,000 Over-Allotment OptionIrving, TX, May 15, 2026 (GLOBE NEWSWIRE) -- Breeze Acquisition Corp. II (NASDAQ:BREZU) (the "Company") announced today the closing of the underwriters' partial exercise of the over-allotment option of 1,500,000 units, at a price to the public of $10.00 per unit, for an aggregate initial public offering of 14,000,000 units. The units began trading on the Nasdaq Global Market under the symbol "BREZU" on May 13, 2026. Each unit consists of one ordinary share and one right. Each right entitles the holder to receive one-fifth (1/5) of one ordinary share upon the consummation of an initial business combination. Once the securities comprising the units begin separate trading, the ordinary share
- PRBreeze Acquisition Corp. II Announces Closing of $125,000,000 Initial Public OfferingIrving, TX, May 14, 2026 (GLOBE NEWSWIRE) -- Breeze Acquisition Corp. II (NASDAQ:BREZU) (the "Company") announced today the closing of its initial public offering of 12,500,000 units, at a price to the public of $10.00 per unit. The units began trading on the Nasdaq Global Market under the symbol "BREZU" on May 13, 2026. Each unit consists of one ordinary share and one right. Each right entitles the holder to receive one-fifth (1/5) of one ordinary share upon the consummation of an initial business combination. Once the securities comprising the units begin separate trading, the ordinary shares and rights are expected to be traded on the Nasdaq Global Market under the symbols "BREZ" and
- SECSEC Form EFFECT filed by Breeze Holdings Acquisition Corp.EFFECT - Breeze Acquisition Corp. II (0002095443) (Filer)
- PRBreeze Acquisition Corp. II Announces Pricing of $125,000,000 Initial Public OfferingIrving, TX, May 12, 2026 (GLOBE NEWSWIRE) -- Breeze Acquisition Corp. II (the "Company") announced today that it priced its initial public offering of 12,500,000 units at a price to the public of $10.00 per unit. The units are expected to commence trading on May 13, 2026 on the Nasdaq Global Market under the symbol "BREZU." Each unit consists of one ordinary share and one right. Each right entitles the holder to receive one-fifth (1/5) of one ordinary share upon the consummation of an initial business combination. Once the securities comprising the units begin separate trading, the ordinary shares and rights are expected to be traded on the Nasdaq Global Market under the symbols "BREZ" a
- INSIDERNew insider Breeze Sponsor Ii, Llc claimed ownership of 4,910,676 units of Ordinary Shares (SEC Form 3)3 - Breeze Acquisition Corp. II (0002095443) (Issuer)
- INSIDERNew insider Ramsey J Douglas claimed ownership of 4,910,676 units of Ordinary Shares (SEC Form 3)3 - Breeze Acquisition Corp. II (0002095443) (Issuer)
- INSIDERNew insider Baldwin Rick claimed ownership of 35,000 units of Ordinary Shares (SEC Form 3)3 - Breeze Acquisition Corp. II (0002095443) (Issuer)
- INSIDERSEC Form 3 filed by new insider Cabell Richard3 - Breeze Acquisition Corp. II (0002095443) (Issuer)
- INSIDERNew insider Pine Michael J claimed ownership of 35,000 units of Ordinary Shares (SEC Form 3)3 - Breeze Acquisition Corp. II (0002095443) (Issuer)
- INSIDERNew insider Balch Charles M claimed ownership of 35,000 units of Ordinary Shares (SEC Form 3)3 - Breeze Acquisition Corp. II (0002095443) (Issuer)
- INSIDERNew insider Przybyslawski Anthony claimed ownership of 35,000 units of Ordinary Shares (SEC Form 3)3 - Breeze Acquisition Corp. II (0002095443) (Issuer)
- SECSEC Form CERT filed by Breeze Holdings Acquisition Corp.CERT - Breeze Acquisition Corp. II (0002095443) (Filer)
- SECSEC Form 8-A12B filed by Breeze Holdings Acquisition Corp.8-A12B - Breeze Acquisition Corp. II (0002095443) (Filer)
- SECAmendment: SEC Form S-1/A filed by Breeze Holdings Acquisition Corp.S-1/A - Breeze Acquisition Corp. II (0002095443) (Filer)
- SECAmendment: SEC Form S-1/A filed by Breeze Holdings Acquisition Corp.S-1/A - Breeze Acquisition Corp. II (0002095443) (Filer)
- PRBreeze Holdings Acquisition Corp. Shareholders Approve Business Combination with YD Biopharma LimitedTransaction Expected to Close in the Coming Days Combined Company to be Named YD Bio Limited and Expectedto Trade on Nasdaq Under Ticker Symbol "YDES" IRVING, Texas, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Breeze Holdings Acquisition Corp. ("Breeze") (OTCQX:BRZH, OTCQB:BRZHR, BRZHW)), a publicly traded special purpose acquisition company, today announced that its stockholders voted to approve the previously announced business combination (the "Business Combination") with YD Biopharma Limited ("YD Biopharma"), a Taiwan–based biopharmaceutical company dedicated to developing, manufacturing and commercializing innovative vaccines and therapeutic biologics for infectious diseases and other indicat
- PRBreeze Holdings Acquisition Corp. Announces Definitive Agreement to Merge with YD Biopharma LimitedYD Biopharma is a Clinical-Stage Biopharmaceutical Company Focusing on Cancer Prevention Diagnostics and Seeking to Transform the Treatment of a Wide Spectrum of Diseases Pro Forma for the Transaction, Combined Company is Expected to Have an Estimated Enterprise Value of Nearly $700 Million The Proposed Merger is Expected to Close by Early 2025; After Closing, the Combined Company is Expected to be Listed on Nasdaq Capital Market YD Biopharma has Recently Obtained Patents, Technology, and U.S. Authorization for Core Methylation Detection of Pancreatic Cancer, Along with Entering into an Agreement to Acquire Licenses for Breast Cancer Detection Upon the Closing of the Mer
- PRBreeze Holdings Acquisition Corp. Provides Update on Trading Status and Potential Business CombinationIRVING, Texas, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Breeze Holdings Acquisition Corp. (OTCQX:BRZH) ("Breeze" or the "Company"), has been informed its application to trade on the OTCQX Best Market has been approved. As a result, the Company's common stock and warrants under the tickers "BRZH" and "BRZHW," respectively, have begun trading on the OTCQX, effective today, August 21, 2024. On August 9, 2024, Breeze filed a Current Report on Form 8-K with the Securities and Exchange Commission (the "SEC") announcing that TV Ammo, Inc. terminated the business combination with Breeze. It remains the intention of the Company to continue pursuing a business combination transaction, and the Company anti
- SECSEC Form 425 filed by Breeze Holdings Acquisition Corp.425 - Breeze Holdings Acquisition Corp. (0001817640) (Subject)
- SECBreeze Holdings Acquisition Corp. filed SEC Form 8-K: Termination of a Material Definitive Agreement8-K - Breeze Holdings Acquisition Corp. (0001817640) (Filer)
- SECSEC Form 25-NSE filed by Breeze Holdings Acquisition Corp.25-NSE - Breeze Holdings Acquisition Corp. (0001817640) (Subject)
BREZ FAQ
6 questionsWhat does Breeze Holdings Acquisition Corp. do?
Breeze Holdings Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in North Richland Hills, Texas.Where does BREZ stock trade?
Breeze Holdings Acquisition Corp. (BREZ) is listed on NASDAQ.What sector and industry is BREZ in?
Breeze Holdings Acquisition Corp. operates in the Finance sector, Blank Checks industry.When did Breeze Holdings Acquisition Corp. go public?
Breeze Holdings Acquisition Corp. (BREZ) completed its IPO in 2020.What companies are similar to BREZ?
Notable peers in the same industry include CVII (Churchill Capital Corp VII), JWSM (Jaws Mustang Acquisition Corp.), HERA (FTAC Hera Acquisition Corp.), CPUH (Compute Health Acquisition Corp.), CONX (CONX Corp.). Compare BREZ side-by-side with any of them on Quantisnow.How can I track BREZ on Quantisnow?
Quantisnow aggregates Breeze Holdings Acquisition Corp.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow BREZ to receive live email and push alerts on every new disclosure.